Named Bioactive Compounds · Compound
Synephrine (Protoalkaloid)
Strong Evidencealkaloid
Hermetica Superfood Encyclopedia
Synephrine is a protoalkaloid derived from bitter orange that acts as a selective β1-adrenergic receptor agonist. It increases metabolic rate by 129-183 kcal daily and enhances fat oxidation through stimulation of lipolytic pathways.
Synephrine is a protoalkaloid primarily sourced from the immature fruits and peel of Citrus aurantium (bitter orange), a plant in the Rutaceae family. It belongs to the phenylethylamine chemical class and is structurally related to ephedrine but with weaker stimulatory effects. Commercial extraction involves solvent-based methods from dried bitter orange peel, yielding extracts standardized to 4-6% p-synephrine content.
A 2022 meta-analysis of placebo-controlled trials found p-synephrine tends to raise blood pressure and heart rate without facilitating weight loss. Key RCTs include an 18-subject crossover trial (PMID: 26948284) showing no cardiovascular effects at 49mg, and a double-blind RCT (PMID: 21537493) demonstrating 50mg p-synephrine increased RMR by up to 183 kcal. A review of ~20 studies involving ~360 subjects confirmed safety at typical doses, though longer trials up to 56 days showed increased RMR without weight loss.
Clinically studied doses range from 30-50mg p-synephrine acutely, or 36-132mg/day for 14-56 days. Standardized bitter orange extracts containing 4-6% p-synephrine (1g extract providing 30-50mg) have been used in RCTs. Isolated p-synephrine at 50mg alone raised RMR without cardiovascular changes. Consult a healthcare provider before starting any new supplement.
Synephrine is a protoalkaloid (phenethylamine derivative) with molecular formula C9H13NO2 and molecular weight 167.21 g/mol. It is not a macronutrient or micronutrient source but a pharmacologically active bioactive compound. Naturally occurring concentrations: bitter orange (Citrus aurantium) peel contains 0.02–0.07% synephrine by dry weight (~200–700 mg/kg); immature fruit (zhi shi) contains higher concentrations of 1–6% by dry weight in some extracts. Standardized commercial extracts are typically standardized to 6% or 10–30% synephrine content. Primary bioactive form: p-synephrine (para-synephrine) is the predominant naturally occurring isomer; m-synephrine (meta-synephrine, oxedrine) is the pharmacologically distinct synthetic form. Oral bioavailability: approximately 30–40% for p-synephrine due to first-pass hepatic metabolism; peak plasma concentration (Tmax) reached within 1–2 hours post-ingestion. Typical studied doses range from 50–100 mg p-synephrine per serving in clinical trials (e.g., 50 mg yielding RMR increase of 129–183 kcal per PMID: 21537493). No meaningful macronutrient (carbohydrate, fat, protein), fiber, vitamin, or mineral content attributable to synephrine itself as an isolated compound. Metabolized primarily via monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT) pathways; co-administration with MAO inhibitors significantly alters metabolism and bioavailability.
Synephrine selectively binds to β1-adrenergic receptors, activating adenylyl cyclase and increasing cAMP levels. This stimulates hormone-sensitive lipase for enhanced lipolysis and increases thermogenesis through uncoupling protein activation. It also inhibits inflammatory pathways by suppressing p38 MAPK and NF-κB signaling cascades.
A double-blind randomized controlled trial demonstrated synephrine increases resting metabolic rate by 129-183 kcal in healthy adults. Multiple studies show enhanced fat oxidation rates during exercise through adrenergic stimulation mechanisms. Anti-inflammatory effects have been documented through p38 MAPK and NF-κB pathway inhibition studies. However, long-term weight loss efficacy requires more extensive clinical investigation.
Synephrine is generally well-tolerated at doses up to 50mg daily, with mild side effects including increased heart rate and blood pressure. It may interact with MAO inhibitors and stimulant medications, potentially causing hypertensive episodes. Individuals with cardiovascular conditions, hypertension, or taking heart medications should avoid synephrine. Safety during pregnancy and lactation has not been established, so use is not recommended.
